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Abstract
Background: The prevalence of type 2 diabetes is higher among African Americans (AA) vs European Americans (EA), 
independent of obesity and other known confounders. Although the reason for this disparity is not known, it is 
possible that relatively low levels of vitamin D among AA may contribute, as vitamin D has been positively associated 
with insulin sensitivity in some studies. The objective of this study was to test the hypothesis that dietary vitamin D 
would be associated with a robust measure of insulin sensitivity in AA and EA women.
Methods: Subjects were 115 African American (AA) and 137 European American (EA) healthy, premenopausal women. 
Dietary intake was determined with 4-day food records; the insulin sensitivity index (SI) with a frequently-sampled 
intravenous glucose tolerance test and minimal modeling; the Homeostasis Model Assessment of Insulin Resistance 
(HOMA-IR) with fasting insulin and glucose; and body composition with dual-energy X-ray absorptiometry.
Results: Vitamin D intake was positively associated with SI (standardized β = 0.18, P = 0.05) and inversely associated 
with HOMA-IR (standardized β = -0.26, P = 0.007) in AA, and the relationships were independent of age, total body fat, 
energy intake, and % kcal from fat. Vitamin D intake was not significantly associated with indices of insulin sensitivity/
resistance in EA (standardized β = 0.03, P = 0.74 and standardized β = 0.02, P = 0.85 for SI and HOMA-IR, respectively). 
Similar to vitamin D, dietary calcium was associated with SI and HOMA-IR among AA but not EA.
Conclusions: This study provides novel findings that dietary vitamin D and calcium were independently associated 
with insulin sensitivity in AA, but not EA. Promotion of these nutrients in the diet may reduce health disparities in type 
2 diabetes risk among AA, although longitudinal and intervention studies are required.
Background
Epidemiological research suggests that low vitamin D
intake is associated with greater risk of type 2 diabetes
[1]. Vitamin D may reduce disease risk by promoting
insulin sensitivity, as suggested by in vitro studies and
associations of 25-hydroxyvitamin D (25(OH)D) with
insulin sensitivity [2,3]. Supplementation trials, however,
have resulted in mixed outcomes, likely due to differences
in the populations and varying measurements of insulin
sensitivity [4]. To our knowledge, no previous study has
investigated whether dietary vitamin D is related to insu-
lin sensitivity.
African Americans (AA) have lower insulin sensitivity
and, subsequently, a greater risk of type 2 diabetes com-
pared to European Americans (EA) [5], although the
cause of this disparity is multi-factorial and not com-
pletely understood. Ethnic differences also exist in vita-
min D status such that AA have lower circulating
25(OH)D and lower intakes of vitamin D than EA [6,7].
Whether ethnic differences in vitamin D status contrib-
ute to the ethnic disparities in type 2 diabetes is not clear.
Ethnic differences may also exist in the relationship of
vitamin D with insulin sensitivity. Analysis of the Third
National Health and Nutrition Examination Survey
(NHANES 1988-1994) revealed inverse associations
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between serum 25(OH)D and the Homeostasis Model
Assessment of Insulin Resistance (HOMA-IR) in EA and
Mexican Americans but not AA [8]. However, indices
derived from fasting insulin and glucose values, such as
HOMA-IR, primarily reflect hepatic insulin resistance
[9], and the accuracy of HOMA-IR in predicting whole-
body insulin sensitivity differs among AA and EA [10].
Thus it is not clear if ethnic differences would exist when
a robust measure of whole-body insulin sensitivity is
used. Further, whether an ethnic difference exists in the
relationship of dietary vitamin D with insulin sensitivity
has not been investigated.
The objective of this study was to examine the relation-
ship of dietary vitamin D with insulin sensitivity in
healthy AA and EA women using both a robust measure
of insulin sensitivity, the frequently-sampled intravenous
glucose tolerance test (FSIGT), and a commonly used
surrogate of whole body insulin resistance, HOMA-IR.
We tested the hypotheses that: 1) dietary vitamin D is
positively associated with insulin sensitivity, independent
of adiposity and total energy intake, and 2) the relation-
ship of dietary vitamin D with insulin sensitivity differs
between AA and EA. As calcium has also been shown to
be associated with insulin sensitivity [11] and to have eth-
nic differences in its relationship with insulin sensitivity
[12], we also examined associations of dietary calcium
with insulin sensitivity in AA and EA women.
Methods
Subjects
Subjects were 252 healthy, premenopausal women (115
AA and 137 EA) who enrolled in one of two studies at the
University of Alabama at Birmingham (UAB) investigat-
ing the role of metabolic factors in the etiology of obesity.
This sub-study uses baseline data collected prior to inter-
vention (where relevant) and includes only subjects who
completed a baseline FSIGT and diet records. Subjects
were recruited through word-of-mouth or newspaper
advertisements, and baseline data were collected between
1995 and 2005. All women were non-smokers, sedentary
(defined as < 2 hrs per week of exercise within the last yr),
consumed < 400 g of alcohol per week, had a history of
regular menstrual cycles, had normal glucose tolerance,
and were not taking medications known to affect body
composition or metabolism. Subject BMI ranges were ≤
25 kg/m2 or 27-30 kg/m2, depending on the protocol. Eth-
nicity was self-defined with both parents and all immedi-
ate grandparents required to be of the same ethnic group.
All research for this study was in compliance with the
Helsinki Declaration and was approved by the UAB Insti-
tutional Review Board for Human use. Informed consent
for all procedures was obtained upon recruitment.
Protocol
Before metabolic testing, subjects completed a 4-wk
weight stabilization period with weights recorded 3 times
weekly and food provided by the General Clinical
R e s e a r c h  C e n t e r  ( G C R C )  d u r i n g  t h e  l a s t  2  w e e k s  t o
ensure weight maintenance and a consistent macronutri-
ent intake. Four-day food records were completed prior
to the weight stabilization period. Insulin sensitivity and
body composition testing were assessed at the GCRC
during an overnight inpatient stay following weight stabi-
lization and while subjects were in the follicular phase of
the menstrual cycle.
Insulin Sensitivity Testing
The insulin sensitivity index (SI) and HOMA-IR were
investigated as indices of insulin sensitivity/resistance. SI,
an index of whole-body insulin sensitivity [13], was
obtained with either a tolbutamide-modified FSIGT or an
insulin-modified FSIGT, as previously described [14,15].
To perform either test, flexible intravenous catheters
were placed in the antecubital spaces of both arms after a
12-hr overnight fast. The average of three blood samples
collected over a 20-min period was used for assessment
of fasting glucose and insulin. Glucose was then intrave-
nously administered (50% dextrose, 11.4 g/m2) at time "0"
and multiple blood samples were collected from times "2
min" through "180 min" relative to glucose administra-
tion. A tolbutamide (125 mg/m2) or insulin (0.02 units/
kg) bolus was injected at time "20 min." Sera were stored
at -85°C until analysis for glucose and insulin, values for
which subsequently were entered into the MINMOD
computer program (version 3.0,© Richard N. Bergman)
for determination of SI [16]. The change in FSIGT proto-
col (tolbutamide vs. insulin-modified) occurred due to
the discontinuation of tolbutamide by the manufacturer.
As SI values measured using the insulin-modified FSIGT
are lower than those obtained with the tolbutamide-mod-
ified FSIGT [17], "test type" was included as a variable in
multiple linear regression models to account for differ-
ences in the tests. HOMA-IR was calculated as [fasting
insulin (μU/ml) × fasting glucose (mmol/L)]/22.5. The SI
value of one woman was not available due to procedural
issues, although fasting values were not affected.
Dietary Intake
A registered dietitian trained subjects to complete 4-day
food records, including 2 weekdays and 2 weekend days.
Food records were analyzed using the Nutrition Data Sys-
tem for Research (NDS-R) software (Nutrition Coordi-
nating Center, University of Minnesota, MN, Database
versions 4.04_32 and 4.05_33, release date 2001-2002).
Food records were analyzed for total kilocalories (kcal), %Alvarez et al. Nutrition & Metabolism 2010, 7:28
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kcal from carbohydrate, fat, and protein, and calcium
(mg/d), and vitamin D (IU/d). Only records with at least 3
of the 4 days completed were used.
Body Composition
Subjects were weighed to the nearest 0.1 kg (Scale-tronix
6702W; Scale-tronix, Carol Stream, IL) in minimal cloth-
ing without shoes, and height was measured without
shoes using a digital stadiometer (Heightronic 235; Mea-
surement Concepts, Snoqualmie, WA). Total body fat and
l e a n  b o d y  m a s s  w e r e  m e a s u r e d  b y  d u a l - e n e r g y  X - r a y
absorptiometry (DXA) using either a GE Lunar Prodigy
densitometer or a Lunar DPX-L densitometer (GE
LUNAR Radiation Corp., Madison, WI) with subjects
lying flat on their backs with their arms to the sides and in
light clothing. Results obtained with these instruments
differ by 4% or less [18] and are accounted for by the addi-
tion of "test type" to regression analyses. DXA data were
available for 114 AA and 135 EA.
Glucose and Insulin Analysis
Serum glucose and insulin were analyzed in the Core
Laboratory of the GCRC and the Clinical Nutrition
Research Center at UAB. Glucose was measured in 10 μl
sera with an Ektachem DT II System (Johnson and John-
son Clinical Diagnostics, Rochester, NY). In the Core
Laboratory, this analysis has a mean intra-assay and inter-
assay coefficient of variation (c.v.) of 0.61% and 1.45%,
respectively. In one study, insulin was assayed in dupli-
cate 200 μl aliquots with Diagnostics Products Corpora-
tion "Coat-A-Count" kits (Los Angeles, CA). In the Core
Laboratory, this assay has a sensitivity of 1.9 μIU/ml, a
mean intra-assay c.v. of 5%, and a mean inter-assay c.v. of
6%. In the other study, insulin was assayed in duplicate
100 μl aliquots using double-antibody radioimmunoassay
(Linco Research, St. Charles, MO) reagents. In the Core
Laboratory, this assay has a sensitivity of 3.35 μIU/ml, a
mean intra-assay c.v. of 3.49%, and a mean inter-assay c.v.
of 5.57%. The difference in insulin assays is accounted for
by the addition of "test type" to regression analyses.
Statistical Analyses
Means and standard deviations for all variables of interest
were computed among all subjects and within each eth-
nic group. Two-group t-tests were used to compare con-
tinuous variables between ethnic groups. Ethnic group
comparisons of subjects tested with an insulin-modified
FSIGT and the Lunar DPX-L DXA machine (indicated in
analyses as "test type 1") were analyzed with the two-
group chi-square test. Pearson correlation analysis was
used to examine the relationships of dietary vitamin D
and calcium with fasting glucose, fasting insulin, HOMA-
IR, and SI. Multiple linear regression analyses were used
to determine if dietary calcium and/or vitamin D intake
was independently related to SI  and HOMA-IR after
adjusting for test type, age, ethnic group, total kcal intake,
% kcal from fat, and total body fat. These statistical analy-
ses were performed among all subjects and separately by
ethnic group. The distributions for SI, vitamin D, calcium,
HOMA-IR, fasting glucose, and fasting insulin deviated
from a normal distribution and were thus log10-trans-
formed. Statistical analyses were performed using the
SAS software package (version 9.1; SAS Institute, Cary,
NC), and statistical tests were 2-sided and assumed a 5%
significance level.
Results
Subject clinical characteristics and reported dietary
intakes by ethnicity are detailed in Table 1. AA and EA
subjects were similar in age, anthropometrics, and body
composition. Fasting glucose and SI were lower in AA vs.
EA (P  < 0.001). Dietary analyses indicated that AA
reported consuming less total kcal (P = 0.02), % kcal from
carbohydrate (P = 0.03), vitamin D (P = 0.01), and cal-
cium (P < 0.001), and greater % kcal from fat (P = 0.03).
The proportion of subjects being tested with insulin-
modified FSIGT and the Lunar DPX-L DXA machine did
not differ significantly by race (AA 77%, EA 71%, P  =
0.24).
Pearson correlation coefficients for dietary vitamin D
and calcium with indices of insulin sensitivity/resistance
are reported in Table 2. Among all subjects, dietary vita-
min D was significantly, positively associated with SI (P =
0.01), and there was a trend towards a significant inverse
association between vitamin D intake and HOMA-IR and
fasting insulin (P = 0.08 for both). Dietary calcium was
significantly, positively associated with SI (P < 0.001). In
multiple linear regression analyses among all subjects,
after adjustment for ethnicity, test type, age, total body
fat, energy intake, and % kcal from fat, a trend towards a
significant, positive association between dietary vitamin
D and SI remained (standardized β = 0.11, P = 0.07), and
dietary vitamin D was significantly, inversely associated
with HOMA-IR (standardized β = -0.15, P = 0.03). Simi-
larly, among all subjects, there was a trend towards a sig-
nificant independent relationship between dietary
calcium and SI (standardized β = 0.13, P  = 0.09), and
dietary calcium was independently, inversely associated
with HOMA-IR (standardized β = -0.17, P = 0.04). If both
dietary vitamin D and calcium were added to the models
as independent variables, neither nutrient was signifi-
cantly associated with SI (P = 0.25 and 0.34, respectively)
or HOMA-IR (P = 0.18 and 0.25, respectively).
Analyses by ethnic group
Correlation analyses by ethnic group, as reported in Table
2, revealed a trend towards a significant, positive associa-Alvarez et al. Nutrition & Metabolism 2010, 7:28
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tion between dietary vitamin D and SI (P = 0.07) and sig-
nificant, inverse associations of dietary vitamin D with
HOMA-IR and fasting insulin (P = 0.02 and 0.03, respec-
tively) and among AA. Dietary vitamin D was not signifi-
cantly associated with any measure of insulin action in
EA, and dietary calcium was not significantly associated
with any measure of insulin action in either EA or AA.
In MLR analysis by ethnic group, the positive associa-
tion between dietary vitamin D and SI  among AA
remained after adjustment for test type, age, total body
fat, energy intake, and % kcal from fat (Figure 1A), and
dietary vitamin D remained significantly, inversely asso-
ciated with HOMA-IR in AA (Figure 1B). Dietary vitamin
D was not significantly associated with SI or HOMA-IR in
EA. Among AA, the independent relationship between
Table 1: Clinical and dietary variables in all subjects combined and by ethnic group
All (n = 252) AA (n = 115) EA(n = 137)
Age (yr) 34.5 ± 6.0 34.0 ± 6.1 34.8 ± 6.0
Weight (kg) 75.3 ± 8.8 74.5 ± 9.0 76.0 ± 8.6
Height (cm) 164.5 ± 6.5 163.6 ± 6.6 165.2 ± 6.3*
BMI (kg/m2) 27.7 ± 2.3 27.8 ± 2.4 27.7 ± 2.2
Total body fat (kg) 31.4 ± 6.6 32.0 ± 6.4 30.6 ± 6.4
Lean body mass (kg) 40.3 ± 4.1 40.3 ± 4.5 40.4 ± 3.8
Fasting glucose (mmol/l)‡ 4.9 ± 0.3 4.8 ± 0.3 5.0 ± 0.3†
Fasting insulin (pmol/l)‡ 77.8 ± 29.9 82.0 ± 35.4 75.0 ± 24.3
HOMA-IR‡ 2.5 ± 1.0 2.6 ± 1.2 2.4 ± 0.8
SI [× 10-4min-1/(μIU/ml)] 3.6 ± 2.8 2.8 ± 2.0 4.3 ± 3.2†
Energy intake (kcal) 1767.2 ± 474.9 1687.2 ± 485.0 1834.3 ± 457.2*
% kcal from carbohydrates 48.1 ± 8.4 46.8 ± 8.8 49.1 ± 7.9*
% kcal from fat 36.8 ± 6.6 37.8 ± 6.8 35.9 ± 6.4*
% kcal from protein 15.5 ± 3.1 15.9 ± 3.1 15.3 ± 3.2
Vitamin D (IU/d) 125.5 ± 83.6 111.5 ± 74.8 133.7 ± 88.9*
Calcium (mg/d) 628.3 ± 279.5 507.9 ± 205.2 729.3 ± 293.8†
Data are presented as mean ± SD. Abbreviations: AA, African American; EA, European American; HOMA-IR, homeostasis model assessment of 
insulin resistance; SI, insulin sensitivity index. Statistical analyses were performed on log10-transformed data for SI, vitamin D, calcium, HOMA-
IR, fasting glucose, and fasting insulin. P for difference between groups determined using a two-group t-test.
*P < 0.05 for difference between ethnic groups
†P < 0.001 for difference between ethnic groups
‡n = 114 AA
Table 2: Pearson correlations of dietary vitamin D and calcium with measures of insulin and glucose metabolism
Vitamin D Calcium
All AA EA All AA EA
Fasting 
glucose
-0.03 -0.13 -0.01 -0.001 -0.07 -0.12
Fasting insulin -0.11* -0.20† 0.01 -0.08 -0.10 -0.03
HOMA-IR -0.11* -0.21† 0.01 -0.08 -0.10 -0.05
SI 0.15† 0.17* 0.06 0.26‡ 0.15 0.13
Pearson correlation coefficient (r) is reported. Abbreviations: FSIGT, frequently-sampled intravenous glucose tolerance test; AA, African 
American; EA, European American; HOMA-IR, homeostasis model assessment of insulin resistance; SI, insulin sensitivity index. Statistical 
analyses were performed on log10-transformed data for SI, vitamin D, calcium, HOMA-IR, fasting glucose, and fasting insulin.
*P = 0.05-0.10
†P < 0.05
‡P < 0.001Alvarez et al. Nutrition & Metabolism 2010, 7:28
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dietary calcium and SI was not significant (P  = 0.16),
although dietary calcium was significantly, inversely asso-
ciated with HOMA-IR (standardized β = -0.23, P  =
0.047). Dietary calcium was not significantly associated
with SI or HOMA-IR in EA (P = 0.31 and P = 0.57 for SI
and HOMA-IR, respectively). Among AA, if both dietary
vitamin D and calcium were added to the MLR models as
independent variables, only vitamin D emerged as a sta-
tistically significant correlate of HOMA-IR (P = 0.046),
whereas neither nutrient was independently associated
with SI (P = 0.15 and 0.58, respectively). Neither vitamin
D nor calcium was significantly associated with SI (P =
0.86 and 0.33, respectively) or HOMA-IR (P = 0.61 and
0.46, respectively) when both nutrients were added to the
MLR models for EA.
Discussion
The objective of this study was to examine the relation-
ships of dietary vitamin D with both whole-body insulin
sensitivity derived from a FSIGT and HOMA-IR, a surro-
gate measure of whole-body insulin sensitivity. Addition-
ally, we sought to determine if the relationships of dietary
vitamin D with insulin sensitivity differed by ethnicity.
Results indicated that, in this sample of women, both
dietary vitamin D and calcium were positively associated
with insulin sensitivity. However, the relationships were
specific for AA women.
To our knowledge, this is the first study to investigate
associations of dietary vitamin D with insulin sensitivity.
In our sample, dietary vitamin D was positively associ-
ated with SI and inversely associated HOMA-IR, inde-
pendent of strong determinants of insulin sensitivity.
Post-hoc comparisons of the relationships of vitamin D
with SI and HOMA-IR indicated that dietary vitamin D
was more strongly associated with HOMA-IR than SI (P =
0.02 determined from POWCOR program [19]). As
HOMA-IR primarily reflects hepatic insulin resistance
[9] and SI captures both hepatic and peripheral insulin
sensitivity [13], dietary vitamin D may be more related to
hepatic insulin sensitivity than peripheral insulin sensi-
tivity.
In analyses by ethnicity, we found dietary vitamin D to
be positively associated with insulin sensitivity in AA but
not EA, indicative of an ethnic difference in the relation-
ship of dietary vitamin D with insulin sensitivity. It is not
clear why the relationship between dietary vitamin D and
insulin sensitivity would be specific for AA. An ethnic
difference in the physiological effects of oral calcitriol has
been noted in that calcitriol increased calcium absorption
to a lesser degree in AA vs. EA premenopausal women
[20]. Given the superior calcium economy of AA, as evi-
denced by resistance to the bone-resorbing effects of
parathyroid hormone and greater renal calcium conser-
vation [6], it is plausible that dietary vitamin D effects are
directed to non-skeletal processes in AA to a greater
extent than in EA. Vitamin D intervention studies com-
p a r i n g  r e s p o n s e s  i n  b o t h  A A  a n d  E A  p o p u l a t i o n s  a r e
required to confirm the ethnic differences.
No other study , to our knowledge, has examined the
role of ethnicity in determining associations between
dietary vitamin D and SI, although Scragg et al. [8]
reported that circulating 25(OH)D was inversely associ-
ated with HOMA-IR in EA but not AA. This finding in
conjunction with ours indicates that among AA dietary
vitamin D may have differential effects on insulin sensi-
tivity than endogenously produced vitamin D, the major
component of serum 25(OH)D. Dietary vitamin D typi-
cally comprises only about 10-20% of circulating vitamin
D [21]. However, considering the limited production of
Figure 1 Independent relationship between vitamin D intake 
and insulin sensitivity in African Americans. A) Vitamin D vs. Insulin 
Sensitivity Index (SI) and B) Vitamin D vs. Homeostasis Model Assess-
ment of Insulin Resistance (HOMA-IR). Relationships are adjusted for 
age, kcal intake, % kcal from fat, total body fat, and test type. The rela-
tionships among European Americans was not statistically significant 
(standardized β = 0.03, P = 0.74 and standardized β = 0.02, P = 0.85 for 
SI and HOMA-IR, respectively).Alvarez et al. Nutrition & Metabolism 2010, 7:28
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endogenous vitamin D in AA [22], dietary vitamin D may
be more important in this ethnic group with regards to
insulin sensitivity. Studies investigating all forms and
sources of vitamin D, including serum 25(OH)D, and
their relationships with robust measures of insulin sensi-
tivity, such as a FSIGT, in multiple ethnic groups are
required.
Analyses using dietary calcium mirrored results of
dietary vitamin D. Previous studies that have reported a
positive association of dietary calcium with insulin sensi-
tivity have not included vitamin D in analyses [11]. In
addition to sharing some of the same food sources (e.g,
fortified milk products and breakfast cereals), both nutri-
ents are involved in regulating intracellular calcium
fluxes which, in turn, are a necessary mediator of insulin
action [3]. Thus it is difficult to distinguish the influences
of one nutrient from the other. On the other hand, vita-
min D has been shown to have direct effects on promot-
ing insulin signaling in vitro [2], and our results showed
that, among AA, vitamin D but not calcium was signifi-
cantly associated with HOMA-IR when both nutrients
were added as independent variables in MLR analyses.
These results suggest that the relationship of vitamin D
with insulin sensitivity, at least in AA, is independent of
calcium. Further study is needed to determine the inde-
pendent influences of these nutrients on insulin sensitiv-
ity, as well as the potential additive effects of vitamin D
and calcium, as has been previously noted [1].
Although the mean intake of both ethnic groups was
below the current Dietary Reference Intakes for vitamin
D and calcium [23], AA reported less vitamin D and cal-
cium intake than EA. This ethnic difference is consistent
with NHANES reports [7,24]. AA are at greater risk for
vitamin D deficiency, not only because of lower vitamin
D intakes, but also due to reduced cutaneous vitamin D3
synthesis secondary to greater melanin pigmentation
[22]. Given the ethnic disparity of lower insulin sensitivity
and greater prevalence of type 2 diabetes among AA, our
finding of beneficial associations of dietary vitamin D and
calcium with insulin sensitivity in this ethnic group has
important clinical and public health implications and
supports the promotion of efforts to increase consump-
tion of vitamin D and calcium-containing foods among
AA.
The major strengths of this study included the use of
robust measures of insulin sensitivity and body composi-
tion. In addition, our ethnic groups were relatively
homogenous in body composition, thus allowing us to
eliminate variations in body composition as potential
confounders. Since the analyses of the food records were
performed, updated data on the vitamin D content of
foods have become available [25], thus it is likely that the
r e p o r t e d  v i t a m i n  D  i n t a k e  i s  u n d e r e s t i m a t e d  w i t h  t h e
NDS-R version used. However, assuming there is no bias-
ing effect on the amount underestimated, the relation-
ships observed should not be affected. The use of food
records is inherently limited due to the tendency of sub-
j e c t s  t o  u n d e r - r e p o r t  f o o d  i n t a k e ;  h o w e v e r ,  d o u b l y -
labeled water analysis in a sub-set of subjects revealed
that both ethnicities under-reported food intake to a sta-
tistically similar degree (data not shown). Furthermore,
the finding of statistically significant results would sug-
gest that more accurate determinants of vitamin D and
calcium intake would only strengthen our findings.
Although general vitamin and mineral supplement use
was not associated with SI and did not differ by ethnic
group (data not shown), we could not differentiate
whether subjects specifically consumed vitamin D and
calcium supplements. In addition, biochemical measures
of calcium or vitamin D intake/absorption (i.e, serum/
urinary calcium or serum 25(OH)D) were not available.
As findings could be related to other unmeasured factors
associated with high vitamin D and calcium intake, future
studies will need to confirm our results using not only
measures of dietary intake, but taking into account spe-
cific dietary supplement intake, serum 25(OH)D, and
serum/urinary calcium. Further, the cross-sectional
nature of the study limits our ability to infer cause-effect
relationships, and our results may not be generalizable to
groups other than AA and EA premenopausal women.
Conclusions
In conclusion, dietary vitamin D and calcium were posi-
tively associated with insulin sensitivity in premeno-
pausal AA but not EA women. Our findings suggest that
promoting dietary vitamin D and calcium intake may be a
practical means of reducing type 2 diabetes risk among
AA. Further studies are required to confirm an insulin-
sensitizing effect of vitamin D and calcium in other popu-
lations, to determine whether such effects are hepatic or
peripheral, to identify independent effects of vitamin D
and calcium, and to determine mechanisms mediating
potential ethnic differences in the relationship of dietary
vitamin D and calcium with insulin sensitivity.
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